Table 3.
Treatment outcomes of new patients with sputum smear positive for acid fast bacilli treated by private practitioner administered directly observed treatment in public-private mix pilot projects, India 2000-02
| Public-private mix project (state) | Evaluation period* | Total No of new case notifications | Cured (%) | Completed treatment (%) | Died (%) | Failed treatment (%) | Defaulted (%) | Transferred (%) | Treatment success (%)† |
|---|---|---|---|---|---|---|---|---|---|
| Private practitioners | |||||||||
| Delhi LRS (New Dehli) | Jan to Mar 2001 | 20 | 18 (90) | 0 | 0 | 1 (5) | 1 (5) | 0 | 90 |
| Kannur (Kerala) | Jan 2001 to Jun 2002 | 85 | 78 (92) | 0 | 2 (2) | 1 (1) | 4 (5) | 0 | 92 |
| Mumbai (Maharashtra) | Apr to Dec 2002 | 296 | 181 (61) | 58 (20) | 7 (2) | 15 (5) | 35 (12) | 0 | 81 |
| Thane Municipal (Maharashtra) | Jan 2001 to Mar 2002 | 215 | 168 (78) | 0 | 10 (5) | 14 (7) | 22 (10) | 1 (0) | 78 |
| Thane Rural (Maharashtra) | Jul 2001 to Jun 2002 | 63 | 55 (87) | 0 | 4 (6) | 0 (0) | 3 (5) | 1 (2) | 87 |
| Corporate and non-governmental organisation | |||||||||
| Mahavir (Andhra Pradesh) | Jan 1995 to Dec 1999 | 161 | 143 (89) | 1 (0) | 3 (2) | 6 (4) | 8 (5) | 0 | 90 |
| Tea Estates (Assam and West Bengal) | Jan 2001 to Mar 2002 | 1925 | 1604 (83) | 17 (1) | 126 (7) | 99 (5) | 77 (4) | 2 (0) | 84 |
| Falah-e-Am (Uttar Pradesh) | Jul 2001 to Jun 2002 | 1040 | 979 (94) | 4 (0) | 26 (3) | 2 (0) | 30 (3) | 0 | 94 |
| NDTB (New Dehli) | Jan 1999 to Dec 2001 | 584 | 508 (87) | 1 (0) | 14 (2) | 29 (5) | 28 (5) | 4 (1) | 87 |
| RK Mission (New Delhi) | Jan 1999 to Dec 2001 | 1429 | 1217 85) | 0 | 40 (3) | 64 (4) | 68 (5) | 40 (3) | 85 |
| Leprosy Rural (Tamil Nadu) | Jul 2000 to Dec 2002 | 472 | 420 (89) | 0 | 28 (6) | 16 (3) | 4 (1) | 4 (1) | 89 |
| St Mary's Leprosy (Tamil Nadu) | Jul 2000 to Dec 2002 | 623 | 514 (82) | 49 (8) | 51 (8) | 4 (1) | 4 (1) | 0 | 91 |
See table 1 for definitions.
*
Patients included if notification as case of tuberculosis and initiation of treatment occurred in specified evaluation period.
†
Proportion of patients documented as cured or completed treatment.